Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Retatrutide is an investigational synthetic peptide and a first-in-class triple-hormone-receptor agonist designed for the treatment of obesity and type 2 diabetes. It mimics the actions of three natural gut hormones: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon.
Retatrutide is an investigational synthetic peptide and a first-in-class triple-hormone-receptor agonist designed for the treatment of obesity and type 2 diabetes. It mimics the actions of three natural gut hormones: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon.